What Are Research Peptides? A Beginner's Guide for Australian Researchers

Research peptides are short chains of amino acids — typically between 2 and 50 residues — supplied for laboratory and scientific research rather than as therapeutic medicines. Larger amino-acid chains above approximately 50 residues are classified as proteins by convention; recombinant proteins like human growth hormone (191 residues) are usually grouped with research peptides in supply terms despite the technical distinction.

A research-grade peptide is identified by three characteristics:

1. Supplied with research-use-only labelling. The product label, COA, and supplier documentation all indicate the compound is for laboratory and scientific research use only — not for human therapeutic use, diagnostic use, or consumption.
2. Manufactured to a research-grade specification. Synthesis is typically by solid-phase peptide synthesis (SPPS) followed by HPLC purification to ≥98% or ≥99% purity. The specification is different from the GMP pharmaceutical manufacturing required for TGA-registered therapeutic goods.
3. Documented with a Certificate of Analysis (COA). Independent third-party testing confirms compound identity (typically by mass spectrometry), purity (HPLC, expressed as a percentage), and the absence of specified contaminants.

This distinction is important because research-grade peptides occupy a different regulatory category from approved pharmaceutical formulations of the same compound. For full regulatory context in Australia, see the Research Peptides Legal Status guide.

Most pharmaceutical drugs and most laboratory research chemicals are small molecules — organic compounds with molecular weights below approximately 500 daltons, typically taken orally and metabolised by liver enzymes (CYP450 family). Peptides differ fundamentally in their physical and pharmacological properties:

Property	Small molecule drugs	Research peptides
Molecular weight	<500 Da typically	200–5,000 Da typically; recombinant proteins can be 20,000+
Synthesis route	Organic chemistry	SPPS or recombinant expression
Oral bioavailability	Often acceptable	Generally poor — degraded by gastric proteases
Administration route	Oral common	Subcutaneous, intramuscular, or intravenous typical
Receptor targeting	Often binds active site of enzymes	Often binds receptor extracellular domains, mimicking endogenous signals
Half-life	Hours to days	Minutes (native) to days (modified analogues)
Storage	Stable as solid at room temp typically	Lyophilised at –20°C; reconstituted refrigerated at 2–8°C

These differences shape research workflow. Peptide research protocols centre on subcutaneous administration, reconstitution from lyophilised powder, refrigerated storage of reconstituted solution, and dose calculations based on volume rather than tablet count. The technique requirements are different from typical small-molecule research.

Research-grade peptides fall into recognisable categories based on the receptors and pathways they target. Five categories cover most of the compounds RetaLABS supplies:

• GLP-1 receptor agonists. Semaglutide, tirzepatide, and retatrutide — incretin-class peptides studied in metabolic, obesity, and cardiovascular research. See the GLP-1 comparison guide.
• Tissue repair peptides. BPC-157, TB-500, and GHK-Cu — studied in tendon, ligament, gut, and skin repair models. See the BPC-157 guide and GHK-Cu guide.
• Growth hormone axis compounds. Recombinant HGH, CJC-1295 (GHRH analog), and Ipamorelin (selective GHS-R agonist) — studied in somatotropic axis, body composition, and IGF-1 research. See the HGH vs secretagogues comparison.
• Cognitive and neuroprotective peptides. Selank, Semax — studied in BDNF/NGF signalling, cerebral protection, and cognitive research. See the cognitive peptides guide.
• Mitochondrial and longevity peptides. MOTS-c, SS-31, NAD+, Epitalon — studied in mitochondrial function, sirtuin signalling, and ageing biology. See the MOTS-c guide and NAD+ research guide.

Other compounds (PT-141, KPV, KLOW blend) fall outside these five primary categories but follow the same supply and handling framework.

Research peptides supplied "for research use only" are a distinct supply category from TGA-approved therapeutic goods. The distinction is based on formulation, intent, and representation rather than on the underlying compound — research-grade semaglutide and the proprietary therapeutic formulations of semaglutide share the same active compound but are different products supplied through different channels under different TGA frameworks.

In practice, research-use-only supply means:

• The compound is supplied for laboratory and scientific research, not for human therapeutic use, diagnostic use, or consumption.
• The supplier does not make therapeutic claims about the compound's effects in humans.
• The supplier does not provide human dosing instructions; research dose references reflect published trial protocols, not therapeutic prescribing.
• The product is supplied with COA documentation establishing identity and purity to research-grade specification.

Researchers purchasing research-grade peptides are responsible for ensuring their use is consistent with the research-only representation and complies with any applicable institutional, state, or federal frameworks for the specific research compound and protocol design. Independent legal advice is appropriate for research projects with specific compliance questions.

The practical workflow for handling a research peptide consists of three steps:

1. Reconstitution. The lyophilised peptide powder is dissolved in bacteriostatic water (sterile water preserved with 0.9% benzyl alcohol). The reconstitution volume determines the final concentration. The RetaLABS Reconstitution Calculator computes volume per dose for any vial size and target concentration.
2. Storage. Lyophilised vials are stored at –20°C, protected from light. Reconstituted solution is refrigerated at 2–8°C and used within 4–6 weeks. Reconstituted solution should not be frozen — freeze-thaw cycling disrupts peptide structure even though the chemical bonds remain intact.
3. Administration. Subcutaneous administration is the standard research route for most peptide classes. See the subcutaneous injection sites guide for site selection, rotation, and technique.

For full procedural references, see the Peptide Reconstitution and Storage Guide and the Research Peptides Sourcing Guide. For the legal framework governing research peptide supply in Australia, see the Research Peptides Legal Status guide.